Medytox Solutions Inc (MMMS) Financial Statements (2024 and earlier)

Company Profile

Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800
WEST PALM BEACH, FL 33401
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8734 - Testing Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6512,4061,7643,1762,7394,141
Cash and cash equivalents6512,4061,7643,1762,7394,141
Deposits current assets  260    
Other undisclosed current assets24,04917,66322,39621,17519,25914,297
Total current assets:24,70020,32924,16024,35121,99918,438
Noncurrent Assets
Property, plant and equipment7,3197,6785,3284,5012,6272,156
Intangible assets, net (including goodwill)7,7077,5768,5087,0556,8904,617
Goodwill3,2793,1405,3173,8643,7001,426
Intangible assets, net (excluding goodwill)4,4284,4363,1913,1913,1913,191
Deferred tax assets, net302253(42)(92)(75)(42)
Other undisclosed noncurrent assets(85)(75)215245198139
Total noncurrent assets:15,24215,43214,01011,7109,6416,870
TOTAL ASSETS:39,94235,76138,16936,06031,63925,308
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,29213,74215,22414,92613,53410,665
Interest and dividends payable      
Taxes payable8,5468,0889,55810,6909,3866,053
Accounts payable3,0573,3572,3012,0281,8401,756
Accrued liabilities2,6892,2973,3662,2092,3072,856
Debt9543,5831,5283,6133,5703,883
Derivative instruments and hedges, liabilities380380    
Due to related parties5,990     
Other undisclosed current liabilities 443   1,502
Total current liabilities:21,61718,14816,75218,53917,10416,049
Noncurrent Liabilities
Long-term debt and lease obligation2,2612,3161,7181,246526448
Long-term debt, excluding current maturities  93100  42
Capital lease obligations2,2612,2231,6181,246526406
Liabilities, other than long-term debt30225342927542
Deferred tax liabilities, net30225342927542
Total noncurrent liabilities:2,5622,5691,7601,337601490
Total liabilities:24,17920,71718,51219,87617,70516,539
Equity
Equity, attributable to parent, including:15,76314,92319,53616,06313,8138,648
Common stock333333
Additional paid in capital5,7145,3575,0633,9293,6801,905
Retained earnings10,0469,56314,47112,13110,1426,752
Other undisclosed equity, attributable to parent0000(12)(12)
Equity, attributable to noncontrolling interest  121121121121121
Total equity:15,76315,04419,65716,18413,9348,769
TOTAL LIABILITIES AND EQUITY:39,94235,76138,16936,06031,63925,308

Income Statement (P&L) ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
Revenues20,12312,54822,82920,78421,06319,168
Revenue, net13,649 22,829   
Cost of revenue
(Cost of Goods and Services Sold)
(4,031)(4,319)(4,137)(4,187)(3,278)(2,583)
Gross profit:16,0918,22918,69316,59717,78516,585
Operating expenses(11,434)(12,194)(11,912)(14,986)(14,198)(10,966)
Other undisclosed operating income (loss)(2,442)654(477)4,1873,2782,583
Operating income (loss):2,215(3,311)6,3045,7986,8648,202
Nonoperating income (expense)17(92)(118)(101)41(153)
Debt instrument, convertible, beneficial conversion feature 247   318
Other nonoperating income (expense)(230)(92)(118)(101)38(170)
Interest and debt expense(230)(198)(119)(101)(97)(142)
Income (loss) from continuing operations before income taxes:2,001(3,600)6,0675,5976,8087,907
Income tax expense (benefit)(978)(311)(2,454)(2,198)(2,598)(7,225)
Income (loss) from continuing operations:1,024(3,911)3,6133,3994,210683
Income (loss) before gain (loss) on sale of properties:1,024(3,911)3,6133,3994,210683
Other undisclosed net income (loss)(17)198119101933,436
Net income (loss):1,007(3,714)3,7313,4994,3044,119
Other undisclosed net loss attributable to parent(523)(1,195)(1,392)(1,511)(914)(1,205)
Net income (loss) attributable to parent:484(4,908)2,3401,9893,3902,914
Preferred stock dividends and other adjustments(523)(1,195)(1,392)(1,511)(914)(3,998)
Net income (loss) available to common stockholders, basic:(39)(6,103)9484782,476(1,084)
Dilutive securities, effect on basic earnings per share4734   
Other undisclosed net income available to common stockholders, diluted5231,1951,392   
Net income (loss) available to common stockholders, diluted:531(4,905)2,3434782,476(1,084)

Comprehensive Income ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
Net income (loss):1,007(3,714)3,7313,4994,3044,119
Comprehensive income (loss), net of tax, attributable to parent:1,007(3,714)3,7313,4994,3044,119

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: